Address: Akpınar Mah. Osmangazi Cad. No:156
Sancaktepe / ISTANBUL / TURKEY
Tel: 0216 398 10 63
Biofarma, one of the most rooted medicine firms of our country with foundations back to 1945, carried out its activities in Mercan district of Istanbul between 1950 and 1989.
Biofarma, which has been purchased by Pharmacist Mustafa ÖNCEL and then turned into Limited Company in 1973, has always been a part of attempts and developments then required with its technological possibilities and expert staff in terms of human drug production. Biofarma has been moved in 1990 from its facilities in Mercan-Istanbul, where it was first established, to the modern facilities with an area of 15.000 m2 on a land of 17.000 m2, and has been turned into a joint stock company in 1998. Today, it is a part of Partners in Life Sciences (PILS) and Citigroup Venture Capital International (CVCI).
Our mission as Biofarma is to produce quality generic drugs at world standards (cGXP) with a respect of environment and awareness of social responsibility.
Our vision as Biofarma is to take part among the global generic drug manufacturers and to make our products available in all world countries.
Allergy / Immunology
CNS / Neurology
Dentistry / Oral
Endocrinology / Metabolics
Gastrointestinal & Hepatology
Gerontology / Aging
Obstetrics / Gynecology
Oncology / Hematology
Respiratory / Pulmonary
Rheumatology / Arthritis
Vitamins and Minerals
In the world’s 18th largest market, recent pricing struggles have pushed some companies to revaluate their…
Arven Pharmaceuticals is the Turkish R&D-based company behind the first biosimilar drug developed and…
Ercin Kugu, CSL Behring’s general manager for Turkey and Israel, highlights the rare disease company’s…
Boehringer Ingelheim (BI), the largest private pharma company in the world, has become the latest Big Pharma player…
After being present in the Turkish market for more than 28 years, MSD seems confident that it will be able to seize…
Over a decade ago, GE Healthcare selected Turkey as an international operational base for its Eastern and Africa…
Dogan Taskent, board member of the Swiss Chamber of Commerce in Turkey, highlights Turkey’s successful response…
Amgen, the American biotech giant, established a direct presence in Turkey in 2010 by acquiring a local generics…
Few Turkish companies are experiencing such a transformational moment as GEN. Just in 2021, the Ankara-based…
The president of the Turkish Health Institutes (TUSEB), Dr Erhan Akdoğan, provides a behind-the-scenes look at…
Ersin Erfa, CEO of Centurion, a Turkish manufacturer, discusses the company’s high ambitions, R&D…